KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Net Margin (2016 - 2026)

Zimmer Biomet Holdings has reported Net Margin over the past 18 years, most recently at 11.42% for Q1 2026.

  • For Q1 2026, Net Margin rose 186.0% year-over-year to 11.42%; the TTM value through Mar 2026 reached 10.56%, up 195.0%, while the annual FY2025 figure was 10.11%, N/A changed from the prior year.
  • Net Margin for Q1 2026 was 11.42% at Zimmer Biomet Holdings, down from 11.83% in the prior quarter.
  • Over five years, Net Margin peaked at 21.63% in Q4 2023 and troughed at 3.54% in Q1 2022.
  • A 5-year average of 9.84% and a median of 11.32% in 2023 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: soared 1624bps in 2023 and later tumbled -2221bps in 2024.
  • Year by year, Net Margin stood at 3.54% in 2022, then soared by 712bps to 21.63% in 2023, then tumbled by -103bps to 0.58% in 2024, then surged by 2145bps to 11.83% in 2025, then fell by -3bps to 11.42% in 2026.
  • Business Quant data shows Net Margin for ZBH at 11.42% in Q1 2026, 11.83% in Q4 2025, and 11.55% in Q3 2025.